Literature DB >> 4530298

Cholera toxin and cell growth: role of membrane gangliosides.

M D Hollenberg, P H Fishman, V Bennett, P Cuatrecasas.   

Abstract

The binding of cholera toxin to three transformed mouse cell lines derived from the same parent strain, and the effects of the toxin on DNA synthesis and adenylate cyclase activity, vary in parallel with the ganglioside composition of the cells. TAL/N cells of early passage, which contain large quantities of gangliosides G(M3), G(M2), G(M1), and G(Dla), as well as the glycosyltransferases necessary for the synthesis of these gangliosides, bind the most cholera toxin and are the most sensitive to its action. TAL/N cells of later passage, which lack chemically detectable G(M1) and G(Dla) and which have no UDP-Gal:G(M2) galactosyltransferase activity, are intermediate in binding and response to the toxin. SVS AL/N cells, which lack G(M2) in addition to G(M1) and G(Dla) and which have little detectable UDP-GalNAc:G(M3)N-acetylgalactosaminyltransferase activity, bind the least amount of toxin. The SVS AL/N cells are the least responsive to inhibition of DNA synthesis and stimulation of adenylate cyclase activity by cholera toxin. Gangliosides (especially G(M1)), which appear to be the natural membrane receptors for cholera toxin, may normally have important roles in the regulation of cell growth and cAMP-mediated responses.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4530298      PMCID: PMC434363          DOI: 10.1073/pnas.71.10.4224

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  Cholera enterotoxin--recent investigations yield insights into transport processes.

Authors:  C C Carpenter
Journal:  Am J Med       Date:  1971-01       Impact factor: 4.965

2.  Sialic acid transferases and sialic acid levels in normal and transformed cells.

Authors:  W J Grimes
Journal:  Biochemistry       Date:  1970-12-22       Impact factor: 3.162

3.  Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography.

Authors:  E Meezan; H C Wu; P H Black; P W Robbins
Journal:  Biochemistry       Date:  1969-06       Impact factor: 3.162

4.  A difference in the architecture of the surface membrane of normal and virally transformed cells.

Authors:  M M Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1969-03       Impact factor: 11.205

5.  Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines.

Authors:  S I Hakomori; W T Murakami
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

6.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. I. Properties.

Authors:  S L Pohl; L Birnbaumer; M Rodbell
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

7.  Cell density-dependent changes of glycolipid concentrations in fibroblasts, and loss of this response in virus-transformed cells.

Authors:  S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1970-12       Impact factor: 11.205

8.  Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells.

Authors:  M Inbar; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

9.  Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines.

Authors:  P T Mora; R O Brady; R M Bradley; V W McFarland
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  25 in total

1.  Effect of cholera toxin on the antiviral and anticellular activities of human leukocyte interferon.

Authors:  A Fuse; T Kuwata
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Mobility of cholera toxin receptors on rat lymphocyte membranes.

Authors:  S W Craig; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

3.  Mechanism of action of cholera toxin and the mobile receptor theory of hormone receptor-adenylate cyclase interactions.

Authors:  V Bennett; E O'Keefe; P Cuatrecasaş
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

4.  Mechanism of activation of adenylate cyclase by Vibrio cholerae enterotoxin. Relations to the mode of activation by hormones.

Authors:  V Bennett; L Mong; P Cuatrecasas
Journal:  J Membr Biol       Date:  1975-11-07       Impact factor: 1.843

5.  Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness.

Authors:  J Moss; P H Fishman; V C Manganiello; M Vaughan; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

6.  Mechanism of activation of adenylate cyclase by Vibrio cholerae enterotoxin.

Authors:  V Bennett; P Cuatrecasas
Journal:  J Membr Biol       Date:  1975-06-03       Impact factor: 1.843

7.  Mechanism of action of choleragen and E. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation.

Authors:  J Moss; M Vaughan
Journal:  Mol Cell Biochem       Date:  1981-07-07       Impact factor: 3.396

8.  Mechanism of action of Vibrio cholerae enterotoxin. Effects on adenylate cyclase of toad and rat erythrocyte plasma membranes.

Authors:  V Bennett; P Cuatrecasas
Journal:  J Membr Biol       Date:  1975-06-03       Impact factor: 1.843

9.  Ganglioside inhibition of fibronectin-mediated cell adhesion to collagen.

Authors:  H K Kleinman; G R Martin; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

10.  The formation of acetylcholine receptor clusters visualized with quantum dots.

Authors:  Lin Geng; Hailong L Zhang; H Benjamin Peng
Journal:  BMC Neurosci       Date:  2009-07-16       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.